Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype.
Mallery SR, Wang D, Santiago B, Pei P, Schwendeman SP, Nieto K, Spinney R, Tong M, Koutras G, Han B, Holpuch A, Lang J. Mallery SR, et al. Among authors: spinney r. Cancer Prev Res (Phila). 2017 Jan;10(1):76-88. doi: 10.1158/1940-6207.CAPR-16-0180. Epub 2016 Oct 18. Cancer Prev Res (Phila). 2017. PMID: 27756753 Free PMC article.
Fenretinide Perturbs Focal Adhesion Kinase in Premalignant and Malignant Human Oral Keratinocytes. Fenretinide's Chemopreventive Mechanisms Include ECM Interactions.
Han BB, Li S, Tong M, Holpuch AS, Spinney R, Wang D, Border MB, Liu Z, Sarode S, Pei P, Schwendeman SP, Mallery SR. Han BB, et al. Among authors: spinney r. Cancer Prev Res (Phila). 2015 May;8(5):419-30. doi: 10.1158/1940-6207.CAPR-14-0418. Epub 2015 Feb 24. Cancer Prev Res (Phila). 2015. PMID: 25712051 Free PMC article.
Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention.
Mallery SR, Wang D, Santiago B, Pei P, Bissonnette C, Jayawardena JA, Schwendeman SP, Spinney R, Lang J. Mallery SR, et al. Among authors: spinney r. Mol Cancer Ther. 2019 Dec;18(12):2308-2320. doi: 10.1158/1535-7163.MCT-19-0361. Epub 2019 Sep 12. Mol Cancer Ther. 2019. PMID: 31515297 Free PMC article.
Fenretinide combines perturbation of signaling kinases, cell-extracellular matrix interactions and matrix metalloproteinase activation to inhibit invasion in oral squamous cell carcinoma cells.
Wang D, Pei P, Shea FF, Bissonnette C, Nieto K, Din C, Liu Y, Schwendeman SP, Lin YX, Spinney R, Mallery SR. Wang D, et al. Among authors: spinney r. Carcinogenesis. 2022 Oct 22;43(9):851-864. doi: 10.1093/carcin/bgac070. Carcinogenesis. 2022. PMID: 35974187 Free PMC article.
55 results